Abstract
Efficacy and Safety of Intravenous Efgartigimod 10 Mg/Kg in Adult Patients with Primary Immune Thrombocytopenia: Advance, a Phase 3 Clinical Trial in Progress
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have